Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Stem cell aging and autoimmunity in rheumatoid arthritis.

Weyand CM, Goronzy JJ.

Trends Mol Med. 2004 Sep;10(9):426-33. Review. No abstract available.

PMID:
15350894
2.

Immunosenescence, autoimmunity, and rheumatoid arthritis.

Weyand CM, Fulbright JW, Goronzy JJ.

Exp Gerontol. 2003 Aug;38(8):833-41. Review.

PMID:
12915205
3.

Telomere erosion: a new link between HLA DR4 and rheumatoid arthritis?

Salmon M, Akbar AN.

Trends Immunol. 2004 Jul;25(7):339-41. Review. No abstract available.

PMID:
15207499
4.
5.

[Proliferation of type II collagen specific T cell response and antibody formation in rheumatoid arthritis and their relations to HLA-DR4].

Zhou Q, Li X, Li R, Zheng WY, Li ZG.

Zhonghua Yi Xue Za Zhi. 2005 Feb 16;85(6):370-3. Chinese.

PMID:
15854524
6.

Premature immunosenescence in rheumatoid arthritis.

Weyand CM, Goronzy JJ.

J Rheumatol. 2002 Jun;29(6):1141-6. No abstract available.

PMID:
12064826
7.

HLA-DR4, mycobacteria, heat-shock proteins, and rheumatoid arthritis.

Rook G, McCulloch J.

Arthritis Rheum. 1992 Dec;35(12):1409-12. No abstract available.

PMID:
1472119
8.

T cells and aging.

Pawelec G, Remarque E, Barnett Y, Solana R.

Front Biosci. 1998 Jan 15;3:d59-99. Review.

PMID:
9421551
9.

T cell repertoire formation and molecular mimicry in rheumatoid arthritis.

Prakken BJ, Carson DA, Albani S.

Curr Dir Autoimmun. 2001;3:51-63. Review. No abstract available.

PMID:
11791471
10.

Gene therapy for rheumatoid arthritis?

Feldmann M.

J Clin Invest. 2001 Jun;107(11):1353. No abstract available.

11.

HLA-DR4 restriction, molecular mimicry and rheumatoid arthritis.

Wilson C, Tiwana H, Ebringer A, Cunningham P, Ettelaie C.

Immunol Today. 1997 Feb;18(2):96-7. No abstract available.

PMID:
9057362
12.

Immunotherapeutic approach to rheumatoid arthritis with anti-idiotypic antibodies to HLA-DR4.

Quagliata F, Schenkelaars EJ, Ferrone S.

Isr J Med Sci. 1993 Feb-Mar;29(2-3):154-9. Review. No abstract available.

PMID:
8468170
13.

Where do T cells stand in rheumatoid arthritis?

Fournier C.

Joint Bone Spine. 2005 Dec;72(6):527-32. Epub 2005 Jun 29. Review.

PMID:
16087382
14.

Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice.

Hill JA, Bell DA, Brintnell W, Yue D, Wehrli B, Jevnikar AM, Lee DM, Hueber W, Robinson WH, Cairns E.

J Exp Med. 2008 Apr 14;205(4):967-79. doi: 10.1084/jem.20072051. Epub 2008 Apr 7.

15.

Altered collagen II peptides inhibited T-cell activation in rheumatoid arthritis.

Li R, Li X, Li Z.

Clin Immunol. 2006 Feb-Mar;118(2-3):317-23. Epub 2005 Dec 15.

PMID:
16343992
16.

Cross-recognition of HLA DR4 alloantigen by virus-specific CD8+ T cells: a new paradigm for self-/nonself-recognition.

Rist M, Smith C, Bell MJ, Burrows SR, Khanna R.

Blood. 2009 Sep 10;114(11):2244-53. doi: 10.1182/blood-2009-05-222596. Epub 2009 Jul 17.

17.

Comment on the article by Calin et al.

[No authors listed]

Arthritis Rheum. 1990 Oct;33(10):1599-600. No abstract available.

PMID:
2222546
18.

Costimulatory pathways in rheumatoid synovitis and T-cell senescence.

Goronzy JJ, Henel G, Sawai H, Singh K, Lee EB, Pryshchep S, Weyand CM.

Ann N Y Acad Sci. 2005 Dec;1062:182-94. Review.

PMID:
16461801
19.

Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.

Sakurai Y, Brand DD, Tang B, Rosloniec EF, Stuart JM, Kang AH, Myers LK.

Arthritis Res Ther. 2006;8(5):R150.

20.

Exploiting T cell crosstalk as a vaccination strategy for rheumatoid arthritis.

Prakken B, Albani S.

Arthritis Rheum. 2007 Feb;56(2):389-92. No abstract available.

Supplemental Content

Support Center